Alternative Transition Trajectories for Complementary Asset Markets in China's Pharmaceutical Industry.

As the State relinquishes its role as coordinator of interorganizational asset transfers, how do interdendent suppliers and users of complementary assets find each other and manage transactions for these assets? This study compares the emerging market structure of two different types of complementary assets in the pharmaceutical industry - new product technology (R&D) and sales and distribution (Wholesaling).

MoreLess

Year of publication:	1997
Authors:	Liu, X. ; White, S.
Subject:	PHARMACEUTICAL INDUSTRY \| FINANCIAL MARKET

Check Google Scholar |

More access options

In German libraries (KVK)

I need help

More details

Type of publication:	Book / Working Paper
Notes:	25 pages
Classification:	L65 - Chemicals; Rubber; Drugs; Biotechnology ; D23 - Organizational Behavior; Transaction Costs; Property Rights
Source:	RePEc - Research Papers in Economics

Persistent link: https://www.econbiz.de/10005671711